Ersoy Guller, Zeynep
Green, Frederick
Goodman, Anna L.
Article History
Received: 9 June 2023
Accepted: 24 July 2023
First Online: 15 August 2023
Declarations
:
: Not applicable.
: Not applicable.
: ZEG and FG have no competing interests to disclose. ALG is named as an inventor on a patent covering use of a particular promoter construct that is often used in ChAdOx1-vectored vaccines and is incorporated in the ChAdOx1 nCoV-19 vaccine. ALG may benefit from royalty income paid to the University of Oxford from sales of this vaccine by AstraZeneca and its sublicensees under the University’s revenue-sharing policy.